Publications and Academic Activities

Publications on Other Topics

Kessous R, Matanes E, Laskov I, Wainstock T, Abitbol J, Yasmeen A, Salvador S, Lau S, Gotlieb WH.
 Carboplatin plus paclitaxel weekly dose dense chemotherapy for high grade ovarian cancer: a re-evaluation.
Acta Obstet Gynecol Scand. 2020 Oct 13. doi: 10.1111/aogs.14023. Online ahead of print.

Jegatheeswaran K, Cormier B, Dube S, Gotlieb WH, Helpman L, Kwon JS, Lau S, Mah S, May T, Saab D, McNeill M, Plante M, Renaud MC, Shamiya S, Vicus D, Parra-Herran C, Feigenberg T.
 Evaluating the diagnostic performance of preoperative endometrial biopsies in patients diagnosed with high grade endometrial cancer: A study of the Society of Gynecologic Oncology (GOC) Community of Practice (CoP).
Gynecol Oncol. 2020 Oct;159(1):52-57. doi: 10.1016/j.ygyno.2020.06.510. Epub 2020 Jul 19.

Cyr MP, Dumoulin C, Bessette P, Pina A, Gotlieb WH, Lapointe-Milot K, Mayrand MH, Morin M.
 Feasibility, acceptability and effects of multimodal pelvic floor physical therapy for gynecological cancer survivors suffering from painful sexual intercourse: A multicenter prospective interventional study.
Gynecol Oncol. 2020 Sep 30:S0090-8258(20)33856-7. doi: 10.1016/j.ygyno.2020.09.001. Online ahead of print.

Vetter MH, Smrz S, Gehrig PA, Peng K, Matsuo K, Davidson BA, Cisa MP, Lees BF, Brunette LL, Tucker K, Stuart Staley A, Gotlieb WH, Holloway RW, Essel KG, Holman LL, Goldfeld E, Olawaiye A, Rose S, Uppal S, Bixel K.
 Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter?
Gynecol Oncol. 2020 Sep 2:S0090-8258(20)33760-4. doi: 10.1016/j.ygyno.2020.08.004. Online ahead of print.

Salvador S, Scott S, Glanc P, Eiriksson L, Jang JH, Sebastianelli A, Dean E.
 Guideline No. 403: Initial Investigation and Management of Adnexal Masses.
J Obstet Gynaecol Can. 2020 Aug;42(8):1021-1029.e3. doi: 10.1016/j.jogc.2019.08.044. 

Le Page C, Amuzu S, Rahimi K, Gotlieb W, Ragoussis J, Tonin PN.
 Lessons learned from understanding chemotherapy resistance in epithelial tubo-ovarian carcinoma from BRCA1and BRCA2mutation carriers.Semin Cancer Biol. 2020 Aug 19:S1044-579X(20)30177-2. doi: 10.1016/j.semcancer.2020.08.005. Online ahead of print.

El-Zein M, Gotlieb W, Gilbert L, Hemmings R, Behr MA, Franco EL; STAIN-IT Study Group.
 Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
Int J Cancer. 2020 Aug 11. doi: 10.1002/ijc.33250. Online ahead of print.

Kogan L, Matanes E, Wissing M, Mitric C, How J, Amajoud Z, Abitbol J, Yasmeen A, López-Ozuna V, Eisenberg N, Lau S, Salvador S, Gotlieb WH.
 The added value of sentinel node mapping in endometrial cancer.
Gynecol Oncol. 2020 Jul;158(1):84-91. doi: 10.1016/j.ygyno.2020.04.687. Epub 2020 Apr 27.

Jeremie Abitbol, Aqsa Munir, Jeffrey How , Susie Lau , Shannon Salvador , Liron Kogan, Roy Kessous , Leslie Breitner , Russell Frank, Beste Kucukyazici, Walter H. Gotlieb.
 The shifting trends towards a robotically-assisted surgical interface: Clinical and financial implications.
Health Policy and Technology 9 (2020) 157–165

Xue Y, Zhu X, Meehan B, Venneti S, Martinez D, Morin G, Maïga RI, Chen H, Papadakis AI, Johnson RM, O'Sullivan MJ, Erdreich-Epstein A, Gotlieb WH, Park M, Judkins AR, Pelletier J, Foulkes WD, Rak J, Huang S.
 SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors.
J Pathol. 2020 Jun 19:e5493. doi: 10.1002/path.5493. Online ahead of print.

Piedimonte S, Kessous R, Laskov I, Abitbol J, Kogan L, Yasmeen A, Salvador S, Lau S, Gotlieb WH.
 Similar Overall Survival Using Neoadjuvant Chemotherapy or Primary Debulking Surgery in Patients Aged Over 75 Years with High-Grade Ovarian Cancer.
J Obstet Gynaecol Can. 2020 May 15:S1701-2163(20)30363-7. doi: 10.1016/j.jogc.2020.04.014. Online ahead of print.

Malagón T, Mayrand MH, Ogilvie G, Gotlieb WH, Blake J, Bouchard C, Franco EL, Kulasingam S.
 Modeling the Balance of Benefits and Harms of Cervical Cancer Screening with Cytology and Human Papillomavirus Testing.
Cancer Epidemiol Biomarkers Prev. 2020 Apr 24. doi: 10.1158/1055-9965.EPI-20-0190. Online ahead of print.

Mitric C, Matanes E, Wissing M, Amajoud Z, Abitbol J, Yasmeen A, López-Ozuna V, Eisenberg N, Laskov I, Lau S, Salvador S, Gotlieb WH, Kogan L.
 The impact of wait times on oncological outcome in high-risk patients with endometrial cancer.
J Surg Oncol. 2020 Apr 14. doi: 10.1002/jso.25929. Online ahead of print.

Grundy A, Ho V, Abrahamowicz M, Parent MÉ, Siemiatycki J, Arseneau J, Gilbert L, Gotlieb WH, Provencher DM, Koushik A.
 Lifetime recreational moderate-to-vigorous physical activity and ovarian cancer risk: A case-control study.
Int J Cancer. 2020 Apr 1;146(7):1800-1809. doi: 10.1002/ijc.32513.

Piedimonte S, Frank C, Laprise C, Quaiattini A, Gotlieb WH.
 Occult Tubal Carcinoma After Risk-Reducing Salpingo-oophorectomy: A Systematic Review.
Obstet Gynecol. 2020 Mar;135(3):498-508. doi: 10.1097/AOG.0000000000003702.

Le Page C, Rahimi K, Rodrigues M, Heinzelmann-Schwarz V, Recio N, Tommasi S, Bataillon G, Portelance L, Golmard L, Meunier L, Tonin PN, Gotlieb W, Yasmeen A, Ray-Coquard I, Labidi-Galy SI, Provencher D, Mes-Masson AM.
 Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis.
Gynecol Oncol. 2020 Feb;156(2):377-386. doi: 10.1016/j.ygyno.2019.11.019.

El-Zein M, Cheishvili D, Gotlieb W, Gilbert L, Hemmings R, Behr MA, Szyf M, Franco EL; MARKER study group.
 Genome-wide DNA methylation profiling identifies two novel genes in cervical neoplasia.
Int J Cancer. 2020 Jan 25. doi: 10.1002/ijc.32880. [Epub ahead of print]

Kessous R, Wissing MD, Piedimonte S, Abitbol J, Kogan L, Laskov I, Yasmeen A, Salvador S, Lau S, Gotlieb WH.
 CA-125 reduction during neoadjuvant chemotherapy is associated with success of cytoreductive surgery and outcome of patients with advanced high-grade ovarian cancer.
Acta Obstet Gynecol Scand. 2020 Jan 18. doi: 10.1111/aogs.13814. [Epub ahead of print]

Octeau D, Kessous R, Klein K, Kogan L, Pelmus M, Ferenczy A, Greenwood CMT, Van Kempen LC, Salvador S, Lau S, Tonin PN, Yasmeen A, Gotlieb WH.
 Outcome-Related Differences in Gene Expression Profiles of High-Grade Serous Ovarian Cancers Following Neoadjuvant Chemotherapy.
Mol Cancer Res. 2019 Dec;17(12):2422-2431. doi: 10.1158/1541-7786.MCR-19-0398. 

Matulonis UA, Walder L, Nøttrup TJ, Bessette P, Mahner S, Gil-Martin M, Kalbacher E, Ledermann JA, Wenham RM, Woie K, Lau S, Marmé F, Casado Herraez A, Hardy-Bessard AC, Banerjee S, Lindahl G, Benigno B, Buscema J, Travers K, Guy H, Mirza MR.
 Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA Trial.
J Clin Oncol. 2019 Dec 1;37(34):3183-3191. doi: 10.1200/JCO.19.00917. 

Auclair MH, Yong PJ, Salvador S, Thurston J, Colgan TTJ, Sebastianelli A.
 Guideline No. 392-Classification and Management of Endometrial Hyperplasia.
J Obstet Gynaecol Can. 2019 Dec;41(12):1789-1800. doi: 10.1016/j.jogc.2019.03.025.

Auclair MH, Yong PJ, Salvador S, Thurston J, Colgan TTJ, Sebastianelli A.
 Directive clinique N° 392-Classification et prise en charge de l'hyperplasie de l'endomètre.
J Obstet Gynaecol Can. 2019 Dec;41(12):1801-1813. doi: 10.1016/j.jogc.2019.07.012.

Octeau D, Abitbol J, Amajoud Z, Laskov I, Ferenczy A, Pelmus M, Eisenberg N, Kessous R, Matanes E, Lau S, Yasmeen A, Lopez-Ozuna V, Salvador S, Gotlieb WH, Kogan L.
 Targeted sequencing of histologically defined serous endometrial cancer reflects prognosis and correlates with preoperative biopsy.
Gynecol Oncol Rep. 2019 Nov 27;30:100521. doi: 10.1016/j.gore.2019.100521.

Wissing M, Mitric C, Amajoud Z, Abitbol J, Yasmeen A, López-Ozuna V, How J, Kessous R, Eisenberg N, Lau S, Salvador S, Gotlieb WH, Kogan L.
 Risk factors for lymph nodes involvement in obese women with endometrial carcinomas
Gynecol Oncol. 2019 Oct;155(1):27-33. doi: 10.1016/j.ygyno.2019.07.016. 

Kessous R, How J, Abitbol J, Puzhakkal S, Kogan L, Yasmeen A, Salvador S, Gotlieb WH, Lau S.
 Triple tracer (blue dye, indocyanine green, and Tc99) compared to double tracer (indocyanine green and Tc99) for sentinel lymph node detection in endometrial cancer: a prospective study with random assignment.
Int J Gynecol Cancer. 2019 Sep;29(7):1121-1125. doi: 10.1136/ijgc-2019-000387. 

Nguyen DB, Czuzoj-Shulman N, Alshaya A, Gotlieb WH, Abenhaim HA.
 The effect of rural vs. urban setting on the management and outcomes of surgery for endometrial cancer.
J Gynecol Obstet Hum Reprod. 2019 Nov;48(9):745-749. doi: 10.1016/j.jogoh.2019.06.001. 

Matanes E, Gotlieb WH.
 Immunotherapy of gynecological cancers.
Best Pract Res Clin Obstet Gynaecol. 2019 Oct;60:97-110. doi: 10.1016/j.bpobgyn.2019.03.005. Review.

El-Zein M, Bouten S, Louvanto K, Gilbert L, Gotlieb WH, Hemmings R, Behr MA, Franco EL; CASSIS Study Group*.
 Predictive Value of HPV Testing in Self-collected and Clinician-Collected Samples Compared with Cytology in Detecting High-grade Cervical Lesions.
Cancer Epidemiol Biomarkers Prev. 2019 Jul;28(7):1134-1140. doi: 10.1158/1055-9965.EPI-18-1338.

Leung L, Grundy A, Siemiatycki J, Arseneau J, Gilbert L, Gotlieb WH, Provencher DM, Aronson KJ, Koushik A.
 Shift Work Patterns, Chronotype, and Epithelial Ovarian Cancer Risk.
Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):987-995. doi: 10.1158/1055-9965.EPI-18-1112.

Xue Y, Meehan B, Macdonald E, Venneti S, Wang XQD, Witkowski L, Jelinic P, Kong T, Martinez D, Morin G, Firlit M, Abedini A, Johnson RM, Cencic R, Patibandla J, Chen H, Papadakis AI, Auguste A, de Rink I, Kerkhoven RM, Bertos N, Gotlieb WH, Clarke BA, Leary A, Witcher M, Guiot MC, Pelletier J, Dostie J, Park M, Judkins AR, Hass R, Levine DA, Rak J, Vanderhyden B, Foulkes WD, Huang S.
 CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary.
Nat Commun. 2019 Feb 4;10(1):558. doi: 10.1038/s41467-018-06958-9.

Baloch T, López-Ozuna VM, Wang Q, Matanis E, Kessous R, Kogan L, Yasmeen A, Gotlieb WH.
 Sequential therapeutic targeting of ovarian Cancer harboring dysfunctional BRCA1.
BMC Cancer. 2019 Jan 10;19(1):44. doi: 10.1186/s12885-018-5250-4.

Francis JA, Eiriksson L, Dean E, Sebastianelli A, Bahoric B, Salvador S.
 No. 370-Management of Squamous Cell Cancer of the Vulva.
J Obstet Gynaecol Can. 2019 Jan;41(1):89-101. doi: 10.1016/j.jogc.2018.07.004.

Francis JA, Eiriksson L, Dean E, Sebastianelli A, Bahoric B, Salvador S.
 No 370 - Prise en charge du cancer spinocellulaire de la vulve.
J Obstet Gynaecol Can. 2019 Jan;41(1):102-115. doi: 10.1016/j.jogc.2018.11.016. Erratum in:  J Obstet Gynaecol Can. 2019 Apr;41(4):575.

Malagón T, Kulasingam S, Mayrand MH, Ogilvie G, Smith L, Bouchard C, Gotlieb W, Franco EL.
 Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
Lancet Oncol. 2018 Dec;19(12):1569-1578. doi: 10.1016/S1470-2045(18)30536-9. Erratum in:  Lancet Oncol. 2019 Jan;20(1):e10.

McCuaig JM, Stockley TL, Shaw P, Fung-Kee-Fung M, Altman AD, Bentley J, Bernardini MQ, Cormier B, Hirte H, Kieser K, MacMillan A, Meschino WS, Panabaker K, Perrier R, Provencher D, Schrader KA, Serfas K, Tomiak E, Wong N, Young SS, Gotlieb WH, Hoskins P, Kim RH; BRCA TtoT Community of Practice.
 Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap.
J Med Genet. 2018 Sep;55(9):571-577. doi: 10.1136/jmedgenet-2018-105472. Review.

Kogan L, Octeau D, Amajoud Z, Abitbol J, Laskov I, Ferenczy A, Pelmus M, Eisenberg N, Kessous R, Lau S, Yasmeen A, Gotlieb WH, Salvador S.
 Impact of lower uterine segment involvement in type II endometrial cancer and the unique mutational profile of serous tumors.(Free PMC Article)
Gynecol Oncol Rep. 2018 Mar 19;24:43-47.

El-Zein M, Bouten S, Louvanto K, Gilbert L, Gotlieb W, Hemmings R, Behr MA, Franco EL; CASSIS Study Group, Liang V, Martins C, Duarte S, Sarban N, Geddes P, Massa A, Samios K, Aboufadl S, Verdon S, Pereria C, Lacroix I.
 Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study.
Gynecol Oncol. 2018 June; 149(3): 491-497. 

Le Page C, Rahimi K, Köbel M, Tonin PN, Meunier L, Portelance L, Bernard M, Nelson BH, Bernardini MQ, Bartlett JMS, Bachvarov D, Gotlieb WH, Gilks B, McAlpine JN, Nachtigal MW, Piché A, Watson PH, Vanderhyden B, Huntsman DG, Provencher DM, Mes-Masson AM.
 Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers.(Free PMC Article)
BMC Cancer. 2018 Mar 27;18(1):347.

Kessous R, Octeau D, Klein K, Tonin PN, Greenwood CMT, Pelmus M, Laskov I, Kogan L, Salvador S, Lau S, Yasmeen A, Gotlieb WH.
 Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer.
Gynecol Oncol. 2018 Mar;148(3):553-558.

How JA, O'Farrell P, Amajoud Z, Lau S, Salvador S, How E, Gotlieb WH.
 Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis.
Minerva Ginecol. 2018 Apr;70(2):194-214.

Piedimonte S, Leung A, Zakhari A, Giordano C, Tellier PP, Lau S.
 Impact of an HPV Education and Vaccination Campaign among Canadian University Students.
J Obstet Gynaecol Can. 2018 Apr;40(4):440-446. doi: 10.1016/j.jogc.2017.07.028.

Salvador S, Scott S, Francis JA, Agrawal A, Giede C.
 Guidelines About Opportunistic Salpingectomy, IVF, and the Practical Side - In Response.
J Obstet Gynaecol Can. 2018 Jan;40(1):15-16. doi: 10.1016/j.jogc.2017.08.001. 

Philip CA, Laskov I, Beauchamp MC, Marques M, Amin O, Bitharas J, Kessous R, Kogan L, Baloch T, Gotlieb WH, Yasmeen A.
 Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors. (Free Article)
BMC Cancer. 2017 Sep 8;17(1):638.

Hoskins PJ, Gotlieb WH.
 Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature. (Free Article)
CA Cancer J Clin. 2017 Nov;67(6):493-506.

Blank N, Laskov I, Kessous R, Kogan L, Lau S, Sebag IA, Gotlieb WH, Rudski L.
Absence of cardiotoxicity with prolonged treatment and large accumulating doses of pegylated liposomal doxorubicin.
Cancer Chemother Pharmacol. 2017 Oct;80(4):737-743.

Kogan L, Laskov I, Amajoud Z, Abitbol J, Yasmeen A, Octeau D, Fatnassi A, Kessous R, Eisenberg N, Lau S, Gotlieb WH, Salvador S.
Dose dense carboplatin paclitaxel improves progression free survival in patients with endometrial cancer.
Gynecol Oncol. 2017 Oct;147(1):30-35.

How J, Boldeanu I, Lau S, Salvador S, How E, Gotlieb R, Abitbol J, Halder A, Amajoud Z, Probst S, Brin S, Gotlieb W.
Unexpected locations of sentinel lymph nodes in endometrial cancer.
Gynecol Oncol. 2017 Oct;147(1):18-23.

Holloway RW, Abu-Rustum NR, Backes FJ, Boggess JF, Gotlieb WH, Jeffrey Lowery W, Rossi EC, Tanner EJ, Wolsky RJ.
Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations.
Gynecol Oncol. 2017 Aug;146(2):405-415.

Salvador S, Scott S, Francis JA, Agrawal A, Giede C.
 No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
J Obstet Gynaecol Can. 2017 Jun;39(6):480-493. doi: 10.1016/j.jogc.2016.12.005.

Salvador S, Scott S, Francis JA, Agrawal A, Giede C.
 No 344-Salpingectomie opportuniste et autres méthodes pour réduire le risque de cancer de l'ovaire, de la trompe de Fallope et du péritoine dans la population générale.
J Obstet Gynaecol Can. 2017 Jun;39(6):494-508. doi: 10.1016/j.jogc.2017.03.121.

Tota JE, Bentley J, Blake J, Coutlée F, Duggan MA, Ferenczy A, Franco EL, Fung-Kee-Fung M, Gotlieb W, Mayrand MH, McLachlin M, Murphy J, Ogilvie G, Ratnam S.
Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm.
Prev Med. 2017 May;98:5-14.

Tota JE, Bentley J, Blake J, Coutlée F, Duggan MA, Ferenczy A, Franco EL, Fung-Kee-Fung M, Gotlieb W, Mayrand MH, McLachlin M, Murphy J, Ogilvie G, Ratnam S.
Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening.
Prev Med. 2017 May;98:15-20.

Koushik A, Grundy A, Abrahamowicz M, Arseneau J, Gilbert L, Gotlieb WH, Lacaille J, Mes-Masson AM, Parent MÉ, Provencher DM, Richardson L, Siemiatycki J.
Hormonal and reproductive factors and the risk of ovarian cancer.
Cancer Causes Control. 2017 May;28(5):393-403.

Greenwald ZR, Huang LN, Wissing MD, Franco EL, Gotlieb WH.
 Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?(Free Article)
Cancer. 2017 May 1;123(9):1545-1554.

How J, Gauthier C, Abitbol J, Lau S, Salvador S, Gotlieb R, Pelmus M, Ferenczy A, Probst S, Brin S, Fatnassi A, Gotlieb W.
Impact of sentinel lymph node mapping on recurrence patterns in endometrial cancer.
Gynecol Oncol. 2017 Mar;144(3):503-509.

Kessous R, Laskov I, Abitbol J, Bitharas J, Yasmeen A, Salvador S, Lau S, Gotlieb WH.
Clinical outcome of neoadjuvant chemotherapy for advanced ovarian cancer.
Gynecol Oncol. 2017 Mar;144(3):474-479.

Black A, Kyriacou J, Drummond N, Power J, Maheu C.
 Fear of cancer recurrence: A study of the experience of survivors of ovarian cancer(Open Access)
Canadian Oncology Nursing Journal. (2017) 27(3): 236-50.

Béland F, Galand C, Fletcher JD, Gotlieb WH, Abitbol J, Julien D.
Defining care trajectories: The example of endometrial cancer.
Journal of Cancer Policy, 2017. 12: p. 21-27.

Hoskins P, Gotlieb W
Ovarian Cancer Screening: UKCTOCS trial
Lancet (2016) 387: 2602-3

Laskov I, Beauchamp MC, Amin O, Nader P, Amber Y, Gotlieb WH.
Metformin Increases E-cadherin in Tumors of Diabetic Patients with Endometrial Cancer and
Suppresses EMT (Epithelial-Mesenchymal-Transition) in Endometrial Cancer Cell Lines
Int J Gynecol Cancer (2016) 26:1213-21

Sun P, Wu Q, Ruan G, Zheng X, Song Y, Zhun J, Wu L, Gotlieb WH
Expression patterns of maspin and mutant p53 are associated with the development of
gestational trophoblastic neoplasia
Oncol Lett. 2016 Nov; 12(5): 3135–3142.

Del Campo JM, Birrer M, Davis C, Fujiwara K, Gollerkeri A, Gore M, Houk B, Lau S, Poveda A, González-Martín A, Muller C, Muro K, Pierce K, Suzuki M, Vermette J, Oza A.
A randomized phase II non-comparative study of PF-04691502 and gedatolisib (PF-05212384) in patients with recurrent endometrial cancer.
Gynecol Oncol. 2016 Jul;142(1):62-69.

Bernardini MQ, Gien LT, Lau S, Altman AD, Gilks B, Ferguson SE, Köbel M, Samouëlian V, Wesa M, Cameron A, Nelson G, Han G, Clarke B, Ho TC, Panzarella T, Atenafu EG, McAlpine JN.
Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC).
Gynecol Oncol. 2016 Apr;141(1):148-54.

Altman AD, Ferguson SE, Atenafu EG, Köbel M, McAlpine JN, Panzarella T, Lau S, Gien LT, Gilks B, Clarke B, Cameron A, Nelson G, Han G, Samouëlian V, Ho TC, Louie K, Bernardini MQ.
Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers.
Gynecol Oncol. 2015 Nov;139(2):268-74.

Amin O, Beauchamp MC, Abou Nader P, Laskov I, Iqbal S, Philip CA, Yasmeen A, Gotlieb WH.

Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors.
BMC Cancer (2015) 15: 817

Hoskins PJ; Fung-Kee-Fung M; Miller D; Gotlieb W.

Time for a level playing field: inequalities in regulatory/approval processes-the example of bevacizumab in epithelial ovarian cancer.

J Clin Oncol. (2015) 33(14):1539-42.

How JA; Abitbol J; Lau S; Gotlieb WH; Abenhaim HA.

The impact of qualitative research on gynaecologic oncology guidelines.

J Obstet Gynaecol Can. (2015) 37(2):138-44.

How J; Lau S; Gotlieb WH
Current role of sentinel lymph node mapping in endometrial cancer.
Indian Journal of Gynecologic Oncology.
November 2015. DOI: 10.1007/s40944-015-0030-4

How J; Gotlieb WH; Press JZ; Abitbol J; Pelmus M; Ferenczy A; Probst S; Gotlieb R; Brin S; Lau S.

Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer.

Gynecologic Oncology. (2015) 137(3):436-42.

How J, Gotlieb WH
Sentinel lymph nodes evaluation in endometrial cancer. In “Uterine Cancer: Diagnosis& Management (2015) Springer Verlag. E. Dinesh Editor

Huang LN, Lau S, Gotlieb WH
Poor outcomes after conservative management for low-grade apparent early-stage endometrial cancer.
ObsetGynecol (2015) May 125: 106

Marques M, Beauchamp MC, Fleury H, Laskov I, Qiang S, Pelmus M, Mes-Masson AM, Gotlieb WH, Witcher M.

Chemotherapy reduces PARP1 in solid tumors: implications for future clinical trials involving PARP inhibitors.
BMC Cancer (2015) 13: 217

Oza AM, Cook AD, Pfisterer J et al.
Standard chemotherapywith or without bevacizumab for women with newly diagnosed ovarian cancer (ICON 7): overall survival results of a phase 3 randomized trial.
Lancet Oncol (2015) 16: 928-36

Rabinovich A; Bernard L; Niazi TM; Ramanakumar AV; Gotlieb WH; Lau S; Bahoric B.

Para-aortic and Pelvic Radiotherapy, an Effective and Safe Treatment in Advanced-stage Uterine Cancer.

Anticancer Research. (2015) 35(5):2893-900.

Rabinovich A, Bernard L, Ramanakumar AV, Stroian G, Gotlieb WH, Lau S, Bahoric B.
Para-aortic and pelvic extended-field radiotherapy for advanced-stage uterine cancer: dosimetric and toxicity comparison between the four-field box and intensity-modulated techniques.
CurrOncol. 2015 Dec;22(6):405-1.

Rabinovich A; Ramanakumar AV; Lau S; Gotlieb WH.

Prolonged pegylated liposomal doxorubicin treatment for recurrent pelvic cancers: a feasibility study.

Acta Obstetricia et Gynecologica Scandinavica. (2015) 94(7):776-80.

Singh SS; Scott S; Bougie O; Leyland N; SOGC Clinical Practice-Gynaecology Committee; Leyland N; Wolfman W; Allaire C; Awadalla A; Bullen A; Burnett M; Goldstein S; Lemyre M; Marcoux V; Potestio F; Rittenberg D; Singh SS; Yeung G; GOC Executive Committee; Hoskins P; Miller D; Gotlieb W; Bernardini M; Hopkins L

Technical update on tissue morcellation during gynaecologic surgery: its uses, complications, and risks of unsuspected malignancy.[Erratum appears in J Obstet Gynaecol Can. 2015 Feb;37(2):107]

Journal of Obstetrics & Gynaecology Canada: JOGC. (2015) 37(1):68-81.

Laskov I, Drudi L, Beauchamp MC, Yasmeen A, Ferenczy A, Pollak M, Gotlieb WH.

Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer.

Gynecol Oncol. (2014) 134: 607-14

Tsoref D, Welch S, Lau S, Biagi J, Tonkin K, Martin LA, Ellard S, Ghatage P, Elit L, Mackay HJ, Allo G, Tsao MS, Kamel-Reid S, Eisenhauer EA, Oza AM.
Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer.
Gynecol Oncol. 2014 Nov;135(2):184-9.

Le Page C, Köbel M, de Ladurantaye M, Rahimi K, Madore J, Babinszky S, Bachvarov DR, Bachvarova M, Beauchamp MC, Cass CE, Chadwick D, Colleen C, Damaraju S, Dufour J, Gotlieb WH, Kalloger SE, Portelance L, McAlpine JN, Matte I, Piché A, Shaw P, Roehrl MH, Vanderhyden BC, Watson PH, Huntsman DG, Provencher DM, Mes-Masson AM.

Specimen quality evaluation in Canadian biobanks participating in the COEUR repository.

Biopreserv Biobank. (2013) 11:83-93.

Drudi L, Press J, Lau S, Gotlieb S, How S, Drummond N, Brin S, Deland S, Gotlieb W.

Vaginal vault dehiscence after robotic hysterectomy in patients with gynecologic cancers: Prospective evaluation and literature review.

Int J Gynecol Cancer (2013) 23:943-50

Niu X, Rajanbabu A, Delisle M, Peng F, Vijaykumar DK, Pavithran K, Feng Y, Lau S, Gotlieb WH, Press J.

Brain metastases in women with epithelial ovarian cancer: multimodal treatment including surgery or gamma-knife radiation is associated with prolonged survival

J Obstet Gynaecol Can (2013) 35:816-22

Gotlieb WH

Fertility preserving treatments in endometrial cancer: The unanswered questions.

Gynecol Oncol (2013) 129: 1-2

Zhang J, Shi Y, Lalonde E, Li L, Cavallone L, Ferenczy A, Gotlieb WH, Foulkes WD, Majewski J.

Exome profiling of primary, metastatic and recurrent ovarian carcinomas in a BRCA1-positive patient.

BMC Cancer (2013) 13:146.

Sieh W, Salvador S, McGuire V, Weber RP, Terry KL, Rossing MA, Risch H, Wu AH, Webb PM, Moysich K, Doherty JA, Felberg A, Miller D, Jordan SJ, Goodman MT, Lurie G, Chang-Claude J, Rudolph A, Kjær SK, Jensen A, Høgdall E, Bandera EV, Olson SH, King MG, Rodriguez-Rodriguez L, Kiemeney LA, Marees T, Massuger LF, van Altena AM, Ness RB, Cramer DW, Pike MC, Pearce CL, Berchuck A, Schildkraut JM, Whittemore AS.

Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.

Int J Epidemiol. 2013; 42 (2): 579-589.

Tone A, Salvador S, Finlayson S,Tinker A, Kwon J, Lee C, Cohen T, Ehlen T, Lee M, Carey M, Heywood M, Pike J, Hoskins P, Stuart G, Swenerton K, Huntsman D Gilks B, Miller D, McAlpine J. The Role of the Fallopian Tube in Ovarian Cancer.

Clin Adv Hematol Oncol, 2012; 10 (5): 296-306.

Crawford B, Piault E, Gotlieb W, Joulain F.

Development and validation of the self-completed ascites impact measure to understand patient

motivation for requesting a paracentesis.

Patient Relat Outcome Meas. (2012) 3:21-30.

How J, Lau S, Press J, Ferenczy A, Pelmus M, Stern J, Probst S, Brin S, Drummond N, Gotlieb W.

Accuracy of sentinel lymph node detection following intra-operative cervical injection for endometrial cancer: A prospective study.

Gynecol Oncol. (2012) 127 (2): 673-7.

Hopkins L, Carrier M, Plante M, Luna V, Gotlieb W, Rambout L.

Surgical venous thromboprophylaxis: a cross-sectional survey of canadian gynaecologic oncologists.

J Obstet Gynaecol Can. 2012 34(7):673-7.

Press JZ, Gotlieb WH.

Controversies in the treatment of early stage endometrial carcinoma.

Obstet Gynecol Int. 2012;2012:578490. Epub 2012 Mar 26

He G, Holcroft CA, Beauchamp MC, Yasmeen A, Ferenczy A, Kendall-Dupont J, Mes-Masson AM, Provencher D, Gotlieb WH.

Combination of serum biomarkers to differentiate malignant from benign ovarian tumors.

J Obstet Gynaecol Can (2012) 34: 567-574

Lau S, Vaknin Z, Agnihotram VR, Franco E, Gotlieb R, How J, Halliday D, Gotlieb WH..

Outcomes and cost following the introduction of a robotics program for endometrial cancer surgery Obstet. Gynecol(2012) 119 (4): 1-10

Gotlieb WH, Amant F, Advani F, Goswami C, Hirte H, Provencher D, Somani D, Yamada D, Tamby J, Vergote I..

Intravenous aflibercept (VEGF Trap) for the treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer : results of a phase II, randomized, double-blind, placebo-controlled study.

Lancet Oncology 2012 13(2):154-62

Fu L, Lau S, Roy I, Ferenczy A.
Phyllodes tumor with malignant stromal morphology of the vulva: a case report and review of the literature.
Int J Gynecol Pathol. 2011 Mar;30(2):198-202.

Perri T, Korach J, Gotlieb WH, Beiner M, Meirow D, Friedman E, Ferenczy A, Ben-Baruch G.

Prolonged conservative treatment of endometrial cancer patients: more than 1 pregnancy can be achieved.

Int J Gynecol Cancer. 2011 Jan;21(1):72-8.

Chen X, Zhang H, Aravindakshan JP, Gotlieb WH, Sairam MR

Anti-proliferative and pro-apoptotic actions of a novel human and mouse ovarian tumor-associated

gene OTAG-12: downregulation, alternative splicing and drug sensitization.

Oncogene. 2011 30 (25): 2874-87

Yasmeen A, Beauchamp MC, Piura E, Segal E, Pollak M, Gotlieb WH

Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins.

Gynecol Oncol. 2011 121 (3) 492-8

Oza AM, Elit L, Tsao MS, Kamel-Reid S, Biagi J, Provencher DM, Gotlieb WH, Hoskins PJ, Ghatage P, Tonkin KS, Mackay HJ, Mazurka J, Sederias J, Ivy P, Dancey JE, Eisenhauer EA.

Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group.

J Clin Oncol. 2011 Aug 20;29(24):3278-85

Segal ED, Yasmeen A, Beauchamp MC, Rosenblatt J, Pollak M, Gotlieb WH.

Relevance of the OCT1 transporter to the antineoplastic effect of biguanides.

Biochem Biophys Res Commun. 2011 414 (4): 694-9

Perren TJ, Swart AM, Pfisterer J, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey

MS, Beale P, Cervantes A, Kurzeder C, du Bois A, Sehouli J, Kimmig R, Stähle A, Collinson F, Essapen S, Gourley C, Lortholary A, Selle F, Mirza MR, Leminen A, Plante M, Stark D, Qian W, Parmar MK, Oza AM, ICON 7 investigators.

A phase 3 trial of bevacizumab in ovarian cancer.

N Engl J Med. (2011) 365(26):2484-96

Reiss A, Gotlieb WH

Molecular Basics of Gynecologic Cancers. In “Textbook of Gyneaecological Oncology”, 2nd edition (2011) ESGO, A Ayhan, N Reed and M Gultekin editors

Reiss A, Gotlieb WH

On the origin of ovarian and endometrial cancers: molecular profiling of gynecologic cancers. In “Recent advances in gynaecologic oncology. (2011) Jaypee brothers,India, Dilip Kumar Dutta eidtor.

Beauchamp MC, Yasmeen A, , Knafo A, Gotlieb WH.

Targeting insulin and insulin-like growth factor (IGF) pathways in epithelial ovarian cancer. Journal of Oncology. (2010) 257058 : 1-11

Perri T, Rahimi K, Ramanakumar AV, Wou K, Pilavdzic D, Franco EL, Gotlieb WH, Ferenczy A. Are endometrial polyps true cancer precursors?

Am J Obstet Gynecol (2010) 203: 232

Hauspy J, Jimenez JW, Rosen B, Gotlieb W, Plante M

Laparoscopic surgery for endometrial cancer

J Obst Gynecol Can (2010) 32:570-9

Henry M, Cohen SR, Lee V, Sauthier P, Provencher D, Drouin P, Gauthier P, Gotlieb W et al.

The meaning-making intervention (MMI) appears to increase meaning in life in advanced ovarian cancer: a randomized controlled pilot study

Psychooncology (2010) 19 (12): 1340-7

Gotlieb WH

Intraperitoneal chemotherapy: why the fuzz?

Int J Gynecol Cancer (2010) 20: S14-6

Salvador S.

Tubal ligation and risk of invasive epithelial ovarian cancer.

MSc thesis. Stanford University, Stanford, California. 2010. Print.

Le T, Giede C, Salem S, Lefebvre G, Rosen B, Bentley J, Kupets R, Power P, Renaud MC, Bryson P, Davis DB, Lau S, Lotocki R, Senikas V, Morin L, Bly S, Butt K, Cargill YM, Denis N, Gagnon R, Hietala-Coyle MA, Lim KI, Ouellet A, Raciot MH; Society of Obstetricians and Gynaecologists of Canada.
Initial evaluation and referral guidelines for management of pelvic/ovarian masses.
J Obstet Gynaecol Can. 2009 Jul;31(7):668-80.

Vaknin Z, Gotlieb WH

Molecular Basics of Gynecologic Cancers. In “Textbook of Gyneaecological Oncology”, 1st edition (2009) ESGO, A Ayhan, N Reed and M Gultekin editors.

Perri T, Gotlieb WH.

Pathogenesis of fallopian tube cancers In 'The Fallopian Tube' (2009) 611-624. Anshan Ltd, Kent, United Kingdom,Allahbadia GN, Saridogan E, Djahanbakhch O, editors.

Tunitsky L, Bruchim I, Lau S, Denschlag D, Gotlieb WH.

Post-operative ascites of unknown etiology in early stage endometrial cancer.

Eur J Surg Oncol (2009) 35 : 785-786

Beauchamp MC, Knafo A, Yasmeen A, Carboni JM, Gottardis MM, Pollak MN, Gotlieb WH.

BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide.

Gynecol. Oncol. (2009) 115: 193-8

Vaknin Z, Gotlieb WH, Arseneau J, Ferenczy A

Papillary serous carcinoma in situ in ovarian endometriosis in a MSH2 carrier

Int J Gynaecol Obstet (2009) 107: 68-69

Bruchim I, Israeli O, Salaheddin MS, Aviram-Goldring A, Rienstein S, Friedman E, Ben-Baruch G, Gotlieb WH

Genetic alterations detected by comparative genomic hybridization and recurrence rate in epithelial ovarian carcinoma

Cancer Genetics and Cytogenetics. (2009)190(2):66-70

Salvador S, Cundiff GW, Simpson ML.

Dinoprostone Vaginal Insert for Labour Induction: A Comparison of Outpatient and Inpatient Settings.

J Obstet Gynaecol Can, 2009; 31 (11): 1028-34.

Salvador S, Gilks B, Köbel M, Huntsman D, Rosen B, Miller D.

The Fallopian Tube: Primary Site of Most Pelvic High-Grade Serous Carcinomas.

Int J Gynecol Cancer, 2009; 19: 58-64.

^ Go to top

Academic Activities Related to Other Topics

AOGQ (Association des Obstetricians et Gynecologue du Quebec)  Annual Meeting 
Role de l’hysterectomie laparoscopique/roboticque au stade precoce du cancer du col uterin: l’experience de l’Hopital general juif
Quebec City, Quebec, Oct. 4, 2019.

IGCS Course: Clinical Application of Molecular Genetics to the Classification and Staging of Endometrial Caancer (Case discussion: Relevance of Macrometastases, Micrometastases, and Isolated Tumour Cells in Sentinel Lymph Nodes)
IGCS Conference Workshop on Treatment of Vascular Complications (Vascular complications)
International Gynecologic Cancer Society Annual Meeting, Rio de Janeiro, Brazil, Sept 19-20, 2019.

La thérapie néoadjuvante et la chirurgie minimalement invasive dans le cancer ovarien
Ovarian Cancer Canada Symposium, Montreal, Québec, Nov. 9, 2018.

21st Century Management of Endometrial Cancer
Department of Obstetrics and Gynecology Grand Rounds Invited International Speaker Forum, Fuzhou Second Hospital
Fuzhou, Fujian, China, Sept. 19, 2018.

Ovarian Cancer
Department of Family Medicine Grand Rounds JGH, Montreal, May 1, 2018.

Round table on the value of medical robotics for the evolution of the health care system.
Centre Hospitalier Universitaire Sainte-Justine (2018), Montreal, Quebec, Apr. 5, 2018.

Vulvar Cancer
2018 Canadian Obstetrics & Gynecology Review Program, Toronto, Feb. 9, 2018.

La cytoréduction robotiseé.
Regroupement des Gynécologues Oncologues du Québec (ROGQ), Mont-Tremblant, Oct. 14, 2017.

Vulvar Cancer
2017 Canadian Obstetrics & Gynecology Review Program, Toronto, Feb 10, 2017.

Tracing decision-making processes in healthcare.
Tracing decision making processes amongst Gyn-Onc in function of gender.
Cutting through surgical decisions in gyn-onc: staff vs. residents.
Biennial International Gynecologic Oncology Society Meeting, Lisbon, Portugal, October 2016

How do MD’s Make Decisions.
Annual General Meeting, Society of Gynecologic Oncology of Canada, Vancouver, June 2016.

Exploring New Regulators of DNA Repair Pathways as Predictors of Response to Chemotherapy
and Overall Prognosis in Ovarian Cancer.
International Symposium on Hereditary Breast and Ovarian Cancer, Montreal, May 2016

Sequential therapeutic targeting of ovarian cancer harboring dysfunctional BRCA 1.
Exploring DNA repair genes expression levels following chemotherapy in high grade serous cancers.
HBOC meeting, Montreal April 2016

Borderline tumors: fertility preservation and pregnancy outcomes
AGOICON, Hyderabad, India, Nov. 2015

Poor outcomes following conservative management for low grade, apparent early stage endometrial cancer.
ACOG meeting, ACOG meeting, San Francisco, May 2015

^ Go to top

Page last updated on 

We always seek feedback to make our site better.